Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Holding BRNS?
Track your performance easily

Barinthus Biotherapeutics (BRNS) Financial Statements

84 Followers

Barinthus Biotherapeutics Financial Overview

Barinthus Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.493; its P/E ratio is -0.94; Barinthus Biotherapeutics is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Jun 23
Income Statement-
Total Revenue$ 14.97M---$ 334.00K
Gross Profit$ 14.97M---$ 334.00K
EBIT$ -8.13M$ -17.63M$ -16.14M$ -18.10M$ -25.50M
EBITDA$ -6.66M$ -16.16M$ -14.71M$ -16.67M$ -24.21M
Net Income Common Stockholders$ -8.11M$ -17.61M$ -15.49M$ -17.29M$ -24.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 142.09M$ 173.03M
Total Assets$ 188.69M$ 186.75M$ 199.48M$ 214.51M$ 246.13M
Total Debt$ 12.67M$ 12.57M$ 12.81M$ 12.98M$ 12.18M
Net Debt$ 12.67M$ 12.57M$ 12.81M$ -129.11M$ -160.85M
Total Liabilities$ 29.23M$ 29.96M$ 27.47M$ 27.51M$ 28.67M
Stockholders Equity$ 159.29M$ 156.62M$ 171.83M$ 186.78M$ 217.21M
Cash Flow-
Free Cash Flow$ -18.31M$ -12.20M$ -12.13M$ -19.45M$ -19.98M
Operating Cash Flow$ -18.20M$ -12.01M$ -11.82M$ -19.60M$ -16.96M
Investing Cash Flow$ -114.00K$ -192.00K$ -308.00K$ 153.00K$ -3.02M
Financing Cash Flow$ 465.00K$ 358.00K$ 503.00K$ 109.00K$ 28.00K
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

Barinthus Biotherapeutics Debt to Assets

Barinthus Biotherapeutics Cash Flow

Barinthus Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis